Literature DB >> 20188462

Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells.

Dong Woo Kang1, Do Sik Min.   

Abstract

Phospholipase D (PLD) has emerged as a critical element in the cell growth signaling. Despite extensive information regarding the regulation of PLD activity in cell survival, the signaling mechanisms that regulate PLD expression in cancer remains poorly understood. Here we investigate that platelet derived growth factor (PDGF) increases PLD1 but not PLD2 expression via Ras-ERK/PI3K-NFkappaB signaling cascade in SK-BR3 breast cancer cells. The two NFkappaB-binding sites are functionally critical for transcriptional activation of PLD1 induced by PDGF. Furthermore, depletion of PLD1 using siRNA significantly abolished PDGF-induced upregulation of matrix metalloproteinase-2 or -9 and invasion of breast cancer cells. Thus, we propose that PDGF-induced PLD1 expression via NFkappaB signaling pathway might contribute to carcinogenesis. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188462     DOI: 10.1016/j.canlet.2010.01.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

Review 1.  PDGF: the nuts and bolts of signalling toolbox.

Authors:  Ammad Ahmad Farooqi; Salman Waseem; Asma M Riaz; Bilal Ahmed Dilawar; Shahzeray Mukhtar; Sehrish Minhaj; Makhdoom Saad Waseem; Suneel Daniel; Beenish Ali Malik; Ali Nawaz; Shahzad Bhatti
Journal:  Tumour Biol       Date:  2011-07-19

2.  Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.

Authors:  Qing Ye; Samuel Kantonen; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2012-12-10       Impact factor: 5.469

3.  Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions.

Authors:  Maoxi Liu; Kunli Du; Zhongxue Fu; Shouru Zhang; Xingye Wu
Journal:  Med Oncol       Date:  2014-11-29       Impact factor: 3.064

4.  Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.

Authors:  Mayur Gadiya; Noriko Mori; Maria D Cao; Yelena Mironchik; Samata Kakkad; Ingrid S Gribbestad; Kristine Glunde; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

5.  Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).

Authors:  Noha Mohamed Said
Journal:  Mol Biol Rep       Date:  2019-01-31       Impact factor: 2.316

6.  Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.

Authors:  Maoxi Liu; Zhongxue Fu; Xingye Wu; Kunli Du; Shouru Zhang; Li Zeng
Journal:  Tumour Biol       Date:  2015-11-27

Review 7.  Functional regulation of phospholipase D expression in cancer and inflammation.

Authors:  Dong Woo Kang; Kang-Yell Choi; Do Sik Min
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

8.  Phospholipase D1 has a pivotal role in interleukin-1β-driven chronic autoimmune arthritis through regulation of NF-κB, hypoxia-inducible factor 1α, and FoxO3a.

Authors:  Dong Woo Kang; Mi-Kyung Park; Hye-Joa Oh; Dong-Gun Lee; Sung-Hwan Park; Kang-Yell Choi; Mi-La Cho; Do Sik Min
Journal:  Mol Cell Biol       Date:  2013-05-20       Impact factor: 4.272

9.  High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.

Authors:  Na Han; Yan-Yan Zhang; Zhong-Mian Zhang; Fang Zhang; Teng-Yuan Zeng; Yi-Bing Zhang; Wen-Chao Zhao
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

10.  The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.

Authors:  Helena M Stricker; Nadine Rommerswinkel; Silvia Keil; Sandina A Gnoth; Bernd Niggemann; Thomas Dittmar
Journal:  Cell Commun Signal       Date:  2021-04-08       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.